Legend: : Special Mention  : Important : Very Important : Key Development |
| |
| Supplementary evidence: |
| |
18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children.
MF Yuen, WL Lim, AO Chan, DK Wong, SS Sum, CL Lai, Clin Gastroenterol Hepatol. 2004 Oct:941-5 |
| |
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.
SA Halperin, G Van Nest, B Smith, S Abtahi, H Whiley, JJ Eiden, Vaccine. 2003 Jun 2:2461-7 |
| |
A randomized control trial on interruption of HBV transmission in uterus.
Q Zhu, G Yu, H Yu, Q Lu, X Gu, Z Dong, X Zhang, Chin Med J (Engl). 2003 May:685-7 |
| |
A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users.
KH Seal, AH Kral, J Lorvick, A McNees, L Gee, BR Edlin, Drug Alcohol Depend. 2003 Aug 20:127-31 |
| |
A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Z Kurug&oeig;l, F Mutluba_, T Ozacar, Vaccine. 2005 Apr 22:2876-80 |
| |
Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine
A GaBaj, G Grze[k, D Borys, A Durmowicz, E Grze[k, L Szadujkis-Szadurski, Wiad Lek. 2004:217-20 |
| |
Comparison of the accelerated and classic vaccination schedules against Hepatitis B: three-week Hepatitis B vaccination schedule provides immediate and protective immunity.
N Salto.lu, AS Inal, Y Tasova, O Kandemir, Ann Clin Microbiol Antimicrob. 2003 Nov 17:10 |
| |
Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents.
MS González-Huezo, F Sánchez-Avila, M García Mayol, G Castro Narro, S Sixtos, M Lisker-Melman, D Kershenobich, Rev Gastroenterol Mex. 2003 Oct-Dec:271-6 |
| |
Efficacy and immune memory of plasma-derived hepatitis B vaccine 11 years after primary immunization
H Xu, G Zhuang, X Wang, Q Chen, Z Chen, Zhonghua Yu Fang Yi Xue Za Zhi. 2000 Mar:113-5 |
| |
Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
NP Singh, SK Mandal, A Thakur, D Kapoor, S Anuradha, A Prakash, R Kohli, SK Agarwal, Ren Fail. 2003 Mar:255-66 |
| |
Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
MG Sasaki, R Foccacia, IJ de Messias-Reason, Vaccine. 2003 Nov 7:4545-9 |
| |
Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
HS Das, P Sawant, RG Shirhatti, K Vyas, S Vispute, S Dhadphale, V Patrawalla, N Desai, Trop Gastroenterol. 2002 Jul-Sep:120-1 |
| |
Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule.
PB Christensen, N Fisker, HB Krarup, E Liebert, N Jaroslavtsev, K Christensen, J Georgsen, Vaccine. 2004 Sep 28:3897-901 |
| |
Immune response to an indigenously developed r-hepatitis B vaccine in mixed population: study of an accelerated vaccination schedule.
A Chowdhury, A Santra, CM Habibullah, AA Khan, J Karunakaramaiah, TS Kishore, AV Raju, S Lahiri, World J Gastroenterol. 2005 Feb 21:1037-9 |
| |
Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and
M Avdicová, V Prikazský, H Hudecková, L Schuerman, P Willems, Eur J Pediatr. 2002 Nov:581-7 |
| |
Immunogenicity in humans of an edible vaccine for hepatitis B.
Y Thanavala, M Mahoney, S Pal, A Scott, L Richter, N Natarajan, P Goodwin, CJ Arntzen, HS Mason, Proc Natl Acad Sci U S A. 2005 Mar 1:3378-82 |
| |
Immunogenicity of low dose intradermal hepatitis B vaccine and its comparison with standard dose intramuscular vaccination.
S Gomber, R Sharma, VG Ramachandran, Indian Pediatr. 2004 Sep:922-6 |
| |
Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B.
RM Martins, G Bensabath, LC Arraes, Mde L Oliveira, JC Miguel, GG Barbosa, LA Camacho, Mem Inst Oswaldo Cruz. 2004 Dec:865-71 |
| |
Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose.
MO Fonseca, LW Pang, N de Paula Cavalheiro, AA Barone, M Heloisa Lopes, Vaccine. 2005 Apr 22:2902-8 |
| |
Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine.
MY Shapira, E Zeira, R Adler, D Shouval, J Hepatol. 2001 Jan:123-7 |
| |
Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view.
MA Rieger, F Hofmann, M Michaelis, Int J Occup Med Environ Health. 2004:379-91 |
| |
Specific hepatitis B vaccine therapy in inactive HBsAg carriers: a randomized controlled trial.
K Yalcin, M Acar, H Degertekin, Infection. 2003 Aug:221-5 |
| |
The efficacy of a two-dose hepatitis B vaccination scheme.
GJ Boland, T van Bommel, A Rulos-van den Berg, JP van den Berg, AM van Loon, J van Hattum, Adv Exp Med Biol. 2003:185-90 |
| |
Therapeutic vaccination in chronic hepatitis B.
H Senturk, F Tabak, M Akdogan, L Erdem, A Mert, R Ozaras, E Sander, G Ozbay, S Badur, J Gastroenterol Hepatol. 2002 Jan:72-6 |
| |
Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection.
B Dikici, AG Kalayci, F Ozgenc, M Bosnak, M Davutoglu, A Ece, T Ozkan, T Ozeke, RV Yagci, K Haspolat, Pediatr Infect Dis J. 2003 Apr:345-9 |